In the News

Khatry: Using Real-World Data in Drug Development & Evaluation

January 25, 2021

Deepak Khatry, Ph.D., a Westat Associate Director and a clinical trials biostatistician, has written Evidence Derived from Real-World Data (RWD): Utility, Constraints, and Cautions, the second chapter in a new book: Real-World Evidence in Drug Development and Evaluation, published in 2021 under the Biostatistics Series of Chapman & Hall/CRC Press.

Dr. Khatry addresses

  • What RWD is in the context of drug development and clinical practice
  • Why RWD is important
  • How RWD can be useful
  • Study designs and statistical methods necessary to ensure high-quality real-world evidence (RWE)

He concludes with actual biopharmaceutical examples and a summary of findings. He also provides cautions and recommendations to researchers and practitioners on the generation and use of real-world evidence.

Written for pharmaceutical industry and clinical practitioners by experienced researchers in the pharmaceutical industry, the book is a single and comprehensive resource to learn about RWE, an emerging and important area of research and application at the forefront of pharmaceutical innovations. The book contains a wide range of real-world evidence examples with applications throughout the lifecycle of drug product development and evidence evaluation.

Back to Top

How can we help?

We welcome messages from job seekers, collaborators, and potential clients and partners.

Get in Contact

Want to work with us?

You’ll be in great company.

Explore Careers